Literature DB >> 20691302

Usefulness of computed tomographic coronary angiography in patients with acute chest pain with and without high-risk features.

Benjamin J W Chow1, Phil Joseph, Yeung Yam, Malek Kass, Li Chen, Rob S Beanlands, Terrence D Ruddy.   

Abstract

The accuracy of 64-slice computed tomographic coronary angiography (CTA) and its ability to direct revascularization in patients with acute chest pain syndrome (ACPS) was investigated. A total of 107 patients with ACPS presenting to the emergency department and referred to cardiology were prospectively enrolled and underwent CTA. From the clinical features, the patients were categorized as having high-risk acute coronary syndrome features or no high-risk features. At the treating physician's discretion, the patients underwent risk stratification with either invasive coronary angiography (ICA) or technetium-99m single photon emission computed tomography. All tests were interpreted by experts unaware of the clinical information. All 52 patients with high-risk acute coronary syndrome features underwent ICA. Of the 55 patients with no high-risk features, 36 underwent single photon emission computed tomography and 19 underwent ICA. The patients were followed up until a decision regarding revascularization was made. Compared with ICA, the operating characteristics of CTA (per-patient analysis) were excellent, with a sensitivity of 98% (95% confidence interval [CI] 87% to 100%), specificity of 100% (95% CI 85% to 100%), positive predictive value of 100% (95% CI 90% to 100%), and negative predictive value of 97% (95% CI 80% to 100%). The agreement between CTA and routine testing (single photon emission computed tomography or ICA) was very good (kappa = 0.94). CTA correctly identified 40 patients (100%) who underwent revascularization and 61 (91.0%) who were treated medically (kappa = 0.88, 95% CI 0.79 to 0.97). In conclusion, CTA might represent a single modality that could be used to triage a wide spectrum of patients with ACPS and could have the potential to rule out coronary disease and identify those who might require revascularization.

Entities:  

Mesh:

Year:  2010        PMID: 20691302     DOI: 10.1016/j.amjcard.2010.03.058

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Imaging techniques for the assessment of suspected acute coronary syndromes in the emergency department.

Authors:  Devang M Dave; Maros Ferencic; Udo Hoffmann; James E Udelson
Journal:  Curr Probl Cardiol       Date:  2014-05-05       Impact factor: 5.200

2.  Comparison of traditional cardiovascular risk models and coronary atherosclerotic plaque as detected by computed tomography for prediction of acute coronary syndrome in patients with acute chest pain.

Authors:  Maros Ferencik; Christopher L Schlett; Fabian Bamberg; Quynh A Truong; John H Nichols; Antonio J Pena; Michael D Shapiro; Ian S Rogers; Sujith Seneviratne; Blair Alden Parry; Ricardo C Cury; Thomas J Brady; David F Brown; John T Nagurney; Udo Hoffmann
Journal:  Acad Emerg Med       Date:  2012-07-31       Impact factor: 3.451

Review 3.  Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department.

Authors:  Maros Ferencik; Udo Hoffmann; Fabian Bamberg; James L Januzzi
Journal:  Eur Heart J       Date:  2016-02-02       Impact factor: 29.983

Review 4.  Coronary CT and the coronary calcium score, the future of ED risk stratification?

Authors:  Leticia Fernandez-Friera; Ana Garcia-Alvarez; Gabriela Guzman; Mario J Garcia
Journal:  Curr Cardiol Rev       Date:  2012-05

5.  Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registry.

Authors:  J E van Velzen; F R de Graaf; L J Kroft; A de Roos; J H C Reiber; J J Bax; J W Jukema; J D Schuijf; M J Schalij; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2011-05-26       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.